Create a Free Account
or
Create a Free Account
or
| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
D. Boral Capital analyst Jason Kolbert maintains Beyond Air (NASDAQ:XAIR) with a Buy and maintains $11 price target.
Financial Guidance for Fiscal Year 2026The Company updated its revenue guidance to $8 to $10 million for the fiscal year ending...
Beyond Air (NASDAQ:XAIR) reported quarterly losses of $(1.25) per share which missed the analyst consensus estimate of $(0.85) ...
Beyond Air, Inc. (NASDAQ: XAIR) ("Beyond Air" or the "Company"), a commercial stage medical device and biopharm...
